
What Is Tianeptine? Warning Issued Over 'Gas Station Heroin'
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
The U.S. Food and Drug Administration (FDA) has stepped up warnings about tianeptine, an unapproved antidepressant increasingly sold in gas stations and convenience stores under names like "Zaza," "Tianna," and "Neptune's Fix."
The substance, dubbed "gas station heroin" for its opioid-like effects, is illegal and not approved for medical use in the U.S., although it is legally marketed in some countries as an antidepressant.
Why It Matters
Tianeptine can be found in some gas stations and convenience stores, often with packaging that mimics legal supplements. Its misuse has drawn increasing attention, particularly due to the way it mimics the effects of opioids, and can cause serious and even fatal side effects.
According to the FDA, poison control center cases involving tianeptine exposure causing severe side effects have increased nationwide, from 11 in total between 2000 and 2013 to 151 in 2020 alone.
What To Know
Despite being illegal, the drug is sometimes illicitly added to foods and beverages or sold as a dietary supplement in the U.S. by some firms.
An FDA spokesperson told Newsweek: "The FDA has taken steps to protect people from tianeptine products, including warning consumers that tianeptine is an unsafe food additive."
The administration has also issued warning letters to companies distributing and selling unlawful tianeptine products, and issued import alerts to stop tianeptine shipments at the border.
A photo provided by the FDA in January 2024 shows bottles of Neptunes Fix Elixir, a product containing tianeptine.
A photo provided by the FDA in January 2024 shows bottles of Neptunes Fix Elixir, a product containing tianeptine.
Uncredited/FDA Office of Regulatory Affairs, Health Fraud Branch via AP
What Is Tianeptine?
Tianeptine acts on the brain's opioid receptors, which can produce feelings of euphoria at high doses, and the products feature claims—without evidence or FDA approval—that they can help users treat medical conditions, including addiction, pain and depression.
"Tianeptine has been used in tens of millions of patients over decades in Europe, Asia and South America and is well documented to be an antidepressant with efficacy roughly similar to first-line antidepressants," Dr. Jonathan A. Javitch, a professor at Columbia University, told Newsweek.
Tianeptine is taken recreationally by some, and has been used to self-treat a variety of ailments, as well as being used chronically. However, abruptly stopping it use can induce withdrawal symptoms similar to those associated with opioids, such as craving, sweating, diarrhea, and others.
"Despite this, it has a remarkably safe track record in Europe and the abuse rate when used clinically is extremely low," Javitch said.
He also said that used clinically, "there is no immediate perceptible effect on mood," and patients do not experience euphoria.
Javitch specializes in experimental therapeutics in psychiatry and is a professor of molecular pharmacology and therapeutics at Columbia.
"Doses six times the clinical dose were shown not to produce euphoria, and thus tianeptine works over time through changing brain chemistry and circuitry and synaptic structure," he said. However, he added that taking high doses in "an uncontrolled way is problematic."
Javitch stressed that he did not believe products containing tianeptine should be sold in "an uncontrolled way with little oversight over dosing or combination with other medication."
According to the FDA, reported adverse effects can include agitation, coma, confusion, death, drowsiness, hypertension, nausea, difficulty breathing, sweating, tachycardia (irregular heartbeat) and vomiting.
In 2024, there was a cluster of illnesses in New Jersey associated with the product "Neptune's Fix," which was found to contain tianeptine and synthetic cannabinoid receptor triggers. Adverse effects included tachycardia, seizure and even death.
FDA Crackdown
The FDA has been taking frequent steps in recent years to warn the public about the dangers of the drug, as well as trying to crack down on companies that include the ingredient in their products.
The agency recommends that health care professionals "encourage patients to avoid all products containing tianeptine, including those claiming to treat an ailment or disorder."
Instead, the FDA said they should speak to their patients about evidence-based treatment options for opioid use disorder, or cases of depression, anxiety, or pain.
States are also taking action independently, and currently a dozen have banned or restricted the sale of tianeptine, including Alabama, Georgia, Michigan, Minnesota, Ohio and Tennessee.
What People Are Saying
Dr. Jonathan A. Javitch, a professor at Columbia University, told Newsweek: "I don't think it should be available at gas stations in an uncontrolled way with little oversight over dosing or combination with other medication. I fear that people will use much higher doses than are clinically indicated, and can escalate dosing and mix with other compounds."
He added: "We just have to remember that tianeptine may have major potential as a treatment for depression and anxiety in the right patients, and we are trying to develop a precision psychiatry approach to predicting just which patients will respond to the mediation when used appropriately."
Commissioner of Food and Drugs Dr. Martin Makary said in a note last month on the subject: "I am very concerned. I want the public to be especially aware of this dangerous product and the serious and continuing risk it poses to America's youth.
"While the FDA is closely following the distribution and sale of these products, it is critical that you appreciate the magnitude of the underlying danger of these products, and disseminate information about it."
He added: "Historically, there has been a delayed recognition of fast-growing trends, such as opioid abuse and vaping addiction in youth. Let's be proactive in understanding and addressing the use of tianeptine products, which are available even to our nation's youth."
What Happens Next
The FDA said it will continue working with local and federal partners to crack down on illegal tianeptine products. It also urged consumers to report any adverse reactions involving tianeptine to the agency's MedWatch program.
This article contains reporting by The Associated Press.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles

Washington Post
33 minutes ago
- Washington Post
West Virginia's near-total abortion pill ban upheld by federal court
A divided federal appeals court on Tuesday allowed West Virginia to restrict access to mifepristone, the pill used to end pregnancies that has emerged as a focal point of legal battles over abortion. The decision marks the first time a federal appeals court has allowed a state to strictly limit the drug, teeing up a key test of states' powers to ban medication approved by the Food and Drug Administration.


The Hill
an hour ago
- The Hill
Appeals court upholds West Virginia's medication abortion ban
A divided federal appeals court panel on Tuesday upheld West Virginia's ban on medication abortion, ruling that the law does not conflict with the Food and Drug Administration's ability to regulate the drug. The U.S. Court of Appeals for the Fourth Circuit dismissed mifepristone manufacturer GenBioPro's effort to strike down West Virginia's near-total abortion ban in a 2-1 decision. The court ruled FDA's approval of mifepristone did not preempt West Virginia's law. GenBioPro produces a majority of the mifepristone sold in the United States, and has held FDA approval for generic mifepristone since 2019. GenBioPro argued that FDA's authority to impose regulations on the prescription and distribution of mifepristone superseded state efforts to restrict access to medications. A lower court ruled against the company, which then appealed the decision. Circuit Judge J. Harvie Wilkinson wrote that a 2007 federal law 'leaves the states free to adopt or diverge from West Virginia's path' and it 'falls well short of expressing a clear intention to displace the states' historic and sovereign right to protect the health and safety of their citizens.' The ruling is the first time a federal appeals court has said states can restrict use of mifepristone. Twenty-eight states restrict access to medication abortions, according to the reproductive health nonprofit Guttmacher Institute. The Supreme Court upheld access to mifepristone last year, when it unanimously dismissed a lawsuit seeking to roll back changes FDA made in 2016 and 2021 to expand access. 'We respect the fact that appellant and some amici have argued that access to mifepristone is important to the health of women in the course of their reproductive choices,' Wilkinson wrote. 'Our objection is not to the substance of this point, but to the venue in which it is advanced.' Wilkinson was appointed by President Reagan. He was joined by U.S. District Judge Rossie Alston, an appointee of President Trump. 'The court is allowing the state to continue putting those seeking medication abortion care in harm's way,' GenBioPro CEO Evan Masingill said in a statement. 'The panel's ruling allows states to restrict access to medications that FDA has deemed safe and effective, threatening a dangerous ripple effect on the availability of essential medications in this country. As we have always made clear, GenBioPro will not stop fighting to ensure all people can access safe, evidence-based healthcare.' West Virginia Gov. Patrick Morrisey (R) said in a statement he was 'proud to see a victory in this case.' 'West Virginia can continue to enforce our pro-life laws and lead the nation in our efforts to protect life. We will always be a pro-life state!' he said. In a dissent, Circuit Judge DeAndrea Gist Benjamin said the state's law 'erects barriers to life-saving healthcare for countless West Virginians in ways not envisioned by Congress.' Benjamin, who was appointed by former President Biden, added that 'the twin sensitivities of abortion access and states' rights cannot influence our willingness to recognize the Food and Drug Administration's (FDA) clear authority in this area.' 'By criminalizing medical providers and prohibiting medication abortions, then, West Virginia has exceeded the ability to regulate abortion as established in Dobbs and has trespassed on the FDA's authority to regulate the safe use of and unburdened access to mifepristone,' Benjamin wrote.


Newsweek
an hour ago
- Newsweek
Men Are Gaining More Confidence From Ozempic Than Women: Report
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. While some may associate Ozempic and other GLP-1 medications with women trying to lose weight, it turns out that men are the ones gaining the most significant confidence boosts from it. In a Kinsey Institute and survey of GLP-1 users, men were three times more likely than women to say GLP-1s gave them more confidence. They also experienced more notable improvements in their dating lives and libidos. Why It Matters In recent years, the use of weight-loss medications called glucagon-like peptide-1 (GLP-1) receptor agonists has surged. Popular products include Ozempic, Mounjaro, Wegovy and Zephound and have been a game changer for many Americans who are obese or have type 2 diabetes. For patients who successfully lose weight, there can be significant changes in their mental health as well as their personal dating lives, but this impact appears to be more pronounced among male users. Ozempic is medicine for adults with type 2 diabetes. Wegovy is prescribed for long-term weight loss in adults and children. Both contain the active ingredient semaglutide, on January 13, 2025, in Sydney, Australia. Ozempic is medicine for adults with type 2 diabetes. Wegovy is prescribed for long-term weight loss in adults and children. Both contain the active ingredient semaglutide, on January 13, 2025, in Sydney, Australia. Steve Christo - Corbis/Corbis via Getty Images What To Know Across the entire survey sample, drugs like Ozempic were having major effects on users' dating lives. While 59 percent of users said the drugs changed their dating experiences, men experienced a more notable impact on their confidence levels and sex lives, according to the report. Men were three times more likely than women to say GLP-1s boosted their confidence and two times more likely to say they were going on more dates. They also reported higher libido, more matches and increased sexual activity. Still, there were some negative implications for men, of which 60 percent said they feared being judged for using GLP-1s and worried they'd be seen as "less masculine" for doing so. Of all GLP-1 users surveyed, 12 percent said they were going on more dates, and 14 percent said they were getting more matches on dating apps. Meanwhile, a whopping 52 percent reported changes in their sex lives. What People Are Saying Dr. Justin Lehmiller, the Kinsey Institute study lead, said in a statement: "I think there's a very nuanced story to tell here. How these drugs impact your sex life will depend on a variety of factors, including drug dosage and drug type, speed of weight loss, starting and ending weight, and how much you changed your health and fitness habits at the same time." "Sexually speaking, it appears that men are experiencing more positive and more negative impacts of GLP-1 medications." What Happens Next The long-term implications of GLP-1 medication use are so far unclear. A recent study discovered a new link between taking GLP-1 drugs and elevated risk of pancreatitis and kidney conditions, including kidney stones. GLP-1 medications are also associated with a higher risk of digestive problems, including nausea, vomiting, diarrhea, and even stomach paralysis in rare cases.